undamentalytics Newsletter

Quantum-si Inc revenue

Quantum-si Inc's revenue was $2.4m in fiscal 2025, down 20.3% on the year before. Over the last twelve months it was $1.6m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Quantum-si Inc: revenue history, annual
Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue001,0823,0582,4361,605
Growth on the year before———+182.6%−20.3%—
Gross profit004881,6001,153562

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $2.3M 93.8% ▼ 21.8%
Services $150,000 6.2% ▲ 12.8%
Geography
Region Revenue Share YoY
Outside the US $1.7M 71.3% ▼ 4.7%
United States $699,000 28.7% ▼ 43.4%

From Quantum-si Inc's 10-K filed March 3, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Quantum-si Inc $1.6m -53.0% 51.8%
Bionexus Gene Lab Corp $3.1m -67.3% -32.9%
YD Bio Ltd $596,817 16.9% —
Ispecimen Inc. $466,302 -92.1% -64.1%
Seer, Inc. $14.2m -12.7% -5.1%
Bionano Genomics, Inc. $30.2m 10.0% -1.4%

Compare with peers

Head to head: BGLC vs QSIQSI vs YDESISPC vs QSI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Quantum-si Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quantum-si Inc.